This in continuation of our letter dated July 29, 2026, this is an update on the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc.

July 31, 2026 BSE Limited National Stock Exchange of India Limited Corporate Service Department, Exchange Plaza, Bandra Kurla Complex, 1st Floor, P. J. Towers, Bandra (E), Dalal Street, Mumbai 400 051 Mumbai 400 001 Scrip Code: 504067 Symbol: ZENSARTECH Sub.: Update on Merger of US subsidiaries Dear Sir, This is in continuation of our letter dated July 29, 2026, wherein we informed you that the Board of Directors of the Company had accorded in-principle approval for the merger of the following US-based 100% step-down subsidiaries with Zensar Technologies Inc., USA, a material wholly owned subsidiary of the Company: i. Bridgeview Life Sciences LLC ii. M3BI LLC In this regard, we wish to inform you that all requisite filings in connection with the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. have been completed with the relevant local authorities/state agencies on July 30, 2026. Accordingly, the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. shall become effective from August 1, 2026. The Company received the intimation of the same at 03:00 a.m. (IST) on July 31, 2026. The filings relating to the merger of M3BI LLC with Zensar Technologies Inc. are currently in progress. This is for your information and records. Thanking you, Yours sincerely, For Zensar Technologies Limited Anand Daga Company Secretary CIN: L72200PN1963PLC012621 www.zensar.com Zensar Technologies Limited, Zensar +( 20) 6607 4000, 2700 4000 investor@zensar.com Knowledge Park, Plot No. 4, MIDC Kharadi, Off Nagar Road, Pune 411014